Compare CXII & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CXII | AQST |
|---|---|---|
| Founded | 2026 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 597.4M | 529.4M |
| IPO Year | 2026 | 2007 |
| Metric | CXII | AQST |
|---|---|---|
| Price | $10.49 | $3.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $9.33 |
| AVG Volume (30 Days) | 27.3K | ★ 2.4M |
| Earning Date | N/A | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,430,000.00 |
| Revenue This Year | N/A | $11.13 |
| Revenue Next Year | N/A | $40.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.77 |
| 52 Week Low | $10.05 | $2.94 |
| 52 Week High | $10.99 | $6.74 |
| Indicator | CXII | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 44.45 | 43.59 |
| Support Level | $10.34 | $3.59 |
| Resistance Level | $10.45 | $4.34 |
| Average True Range (ATR) | 0.03 | 0.25 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 41.18 | 41.85 |
Churchill Capital Corp XII is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.